Trump Tariff Block: Analyst Bullish on TCS, L&T, Bajaj Auto
The recent news of the US court blocking President Trump’s tariff orders has sent shockwaves across the global market. For Indian exporters, this development is a potential game changer. According to Adarsh Nimborkar, an investment advisor, this legal intervention marks a significant shift in global trade dynamics, and he sees near-term upside in stocks like TCS, Bajaj Auto, L&T, and Sun Pharma.
The US court’s decision to block Trump’s tariff orders is a major relief for Indian exporters, who were facing a 25% tariff on steel and 10% on aluminum imports. The tariffs, which were imposed in March 2018, were seen as a major threat to India’s exports, particularly in the engineering and automotive sectors.
The reversal of the tariffs is expected to benefit Indian companies that rely heavily on exports to the US. TCS, one of India’s largest IT services companies, is one of the stocks that stands to gain the most from this development. The company’s revenue from the US market is significant, and the elimination of tariffs will help to reduce its costs and increase its competitiveness in the market.
Another stock that is expected to benefit from this development is Bajaj Auto, India’s largest two-wheeler manufacturer. The company’s exports to the US are significant, and the elimination of tariffs will help to reduce its costs and increase its competitiveness in the market. Bajaj Auto’s stock has been under pressure in recent months due to the impact of the tariffs, but this development could be a major catalyst for the stock.
L&T, one of India’s largest engineering and construction companies, is also expected to benefit from this development. The company’s exports to the US are significant, and the elimination of tariffs will help to reduce its costs and increase its competitiveness in the market. L&T’s stock has been under pressure in recent months due to the impact of the tariffs, but this development could be a major catalyst for the stock.
Sun Pharma, one of India’s largest pharmaceutical companies, is also expected to benefit from this development. The company’s exports to the US are significant, and the elimination of tariffs will help to reduce its costs and increase its competitiveness in the market. Sun Pharma’s stock has been under pressure in recent months due to the impact of the tariffs, but this development could be a major catalyst for the stock.
In addition to these stocks, other Indian companies that are expected to benefit from this development include Tata Steel, JSW Steel, and Hindalco Industries. These companies are major producers of steel and aluminum, and the elimination of tariffs will help to reduce their costs and increase their competitiveness in the market.
The reversal of the tariffs is also expected to have a positive impact on India’s economy as a whole. The tariffs had been a major threat to India’s exports, particularly in the engineering and automotive sectors. The elimination of the tariffs will help to boost India’s exports and support economic growth.
In conclusion, the US court’s decision to block President Trump’s tariff orders is a major relief for Indian exporters, and it is expected to have a positive impact on the stock market. Stocks like TCS, Bajaj Auto, L&T, and Sun Pharma are expected to benefit from this development, and the elimination of tariffs will help to boost India’s exports and support economic growth.
